CN Patent

CN101209243B — 一种脂质体药物及其制备方法

Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2010-12-08 · 15y expired

What this patent protects

本发明涉及一种脂质体药物及其制备方法，特别是涉及米托蒽醌的脂质体制剂及其制备方法。该脂质体药物的特征在于脂质体的粒度在30～80nm之间，并含有：1)活性成分为多价离子药物，它可以和脂质体内的多价反离子形成难以溶解的沉淀；2)磷脂双分子层含有Tm高于体温的磷脂；以及其他可作为脂质体药物的辅料。

USPTO Abstract

本发明涉及一种脂质体药物及其制备方法，特别是涉及米托蒽醌的脂质体制剂及其制备方法。该脂质体药物的特征在于脂质体的粒度在30～80nm之间，并含有：1)活性成分为多价离子药物，它可以和脂质体内的多价反离子形成难以溶解的沉淀；2)磷脂双分子层含有Tm高于体温的磷脂；以及其他可作为脂质体药物的辅料。

Drugs covered by this patent

Patent Metadata

Patent number
CN101209243B
Jurisdiction
CN
Classification
—
Expires
2010-12-08
Drug substance claim
No
Drug product claim
No
Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.